Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the ...

Zimbabwe has launched lenacapavir, an HIV prevention drug administered biannually, aiming to curb infections. While offering ...

Zimbabwe introduces lenacapavir, a new HIV prevention drug administered twice a year, offering hope for high-risk groups but ...

Zimbabwe's health authorities began administering the long-acting HIV prevention drug lenacapavir, making the country one of ...

ZIMBABWE has officially launched the long-acting HIV prevention injection lenacapavir, with the United States pledging to ...

Zimbabwe launches lenacapavir, a long-acting HIV prevention drug, aiming to reduce new infections among high-risk groups with ...

Lab technician Xolile Mhlanga works on lenacapavir at the Desmond Tutu Health Foundation's Masiphumelele Research Site, in ...

Zimbabwe is one of the first countries to introduce the HIV prevention drug lenacapavir. The program aims to target over 46,000 high-risk individuals, backed by U.S. funding and the Global Fund.

South Africa will launch Lenacapavir, a six-month HIV prevention injection, in six provinces, targeting all HIV-negative individuals to curb new infections.

Zimbabwe is now one of the first countries in the world to start a lenacapavir program, which was made possible through funding from the United States government and The Global Fund.

Kenya will roll out a groundbreaking new HIV-prevention drug in March across 15 priority regions, the health ministry said on Wednesday.